CN1229653A - Chinese herbs medicine for preventing and treating hepatitis B - Google Patents
Chinese herbs medicine for preventing and treating hepatitis B Download PDFInfo
- Publication number
- CN1229653A CN1229653A CN 98100776 CN98100776A CN1229653A CN 1229653 A CN1229653 A CN 1229653A CN 98100776 CN98100776 CN 98100776 CN 98100776 A CN98100776 A CN 98100776A CN 1229653 A CN1229653 A CN 1229653A
- Authority
- CN
- China
- Prior art keywords
- herba
- gram
- pair
- content
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for preventing and curing hepatitis B features that it contains Pilose bushlover herb (20-30g), Indian kalimeris herb (20-30g), the straw of glutinous rice (15-20g), etc. Its advantages include high curative effect, no toxic by-effect and easy preparing .
Description
Medicine of the present invention relates to the Chinese herbal medicine of preventing and treating hepatitis.
Hepatitis is a kind of very serious infectious disease of people ' s health that endangers, and its spread speed is fast, scope is wide, hepatitis B sickness rate height especially, and the course of treatment is long, very easily is converted into hepatic ascites, liver cirrhosis even hepatocarcinoma.Be one of the mankind's several principal diseases of demanding urgently conquering.Though the medicine of treatment hepatitis B is many at present, curative effect is unsatisfactory, some Western medicine such as medicines such as interferon, transfer factor, price height, curative effect is general, and the knock-on rate is higher, and difficult quilt generally adopts, some Chinese herbal medicine low prices, curative effect is also undesirable, and its male negative conversion rate is lower.In order to prevent and treat hepatitis B effectively, will effective in cure height, cost is low, be suitable for the medicine that extensive patients is taken.
The medicine that the purpose of this invention is to provide a kind of curative effect height, no side effects, inexpensive control hepatitis B.Medicine of the present invention is a kind of Chinese herbal medicine, its prescription composition contains Herba Artemisiae Scopariae, Carapax Trionycis, Poria, Semen Phaseoli, Spica Prunellae, Radix Bupleuri, Radix Glycyrrhizae etc. and has removing liver heat and toxic substances, outside the conventional medicament of human body immunity improving power, also contain Herba lespedezae pilosae, Herba Kalimeridis grass, Herba Salviae Chinensis, LUODIHONG, Oryza sativa L. var. glutinosa Matsum. grass.Herba lespedezae pilosae content is the 20-30 gram in every auxiliary medicine, Herba Kalimeridis grass 20-30 gram, Herba Salviae Chinensis 15-20 gram; LUODIHONG 20-25 gram, Oryza sativa L. var. glutinosa Matsum. grass 15-20 gram.
Above-mentioned prescription has following characteristics: 1) heat-clearing and toxic substances removing, press down and kill hepatitis B virus, 2) human body immunity improving power, 3) improve hepatic blood flow, enhance metabolism.
Processing procedure is: take by weighing said medicine and be placed in the earth pot, soaked 20 minutes with 500 milliliters of clear water, decoct with slow fire then, boil half an hour, leach medicinal liquid, the medicinal liquid that leaches is concentrated again, get final product until being concentrated to 200 milliliters of left stones.Take 100 milliliters when the patient takes at every turn, take for twice on the one.
Model case of the present invention is as follows:
1,1964, poplar * * women 26 years old, suffer from hepatitis B, through hospitalization repeatedly, outbreak repeatedly, the state of an illness is more and more heavier, 1971 is slight liver cirrhosis through ultrasound investigation, hepatalgia in 1973, ascites, feel sick anorexia, One's face was sallow, lip is black purple, the total loss work capacity, begin to take medicine of the present invention, take that liver pain alleviates after one month, feeling sick disappears, appetite doubles, and ascites disappears, and body weight is increased to 50 kilograms by 44 kilograms.Continue to take January, symptom all disappears, and all indexs are all recovered normally, and take one month, to consolidate curative effect.So far not recurrence again in 23 years.
2,1973, open * * man 35 years old, suffer from hepatitis B, the hospitalization commentaries on classics of not getting better half a year, liver function index is undesired all the time, and through taking medicine of the present invention after one month, liver function index is all normal, the mastery of going home of leaving hospital, continued to take this medicine one month, and consolidated curative effect, so far not recurrence.
3, nineteen ninety, cattle * * male 30 years old, suffer from hepatitis B, do not heal liver function instability, disability through curing in many ways.Took medicine of the present invention one month in 1992, symptom all disappears, and it is normal that liver function indexes recovers, and progressively take part in the work, not recurrence in 4 years so far.Medicine of the present invention is through the clinical trial in more than 20 years, is 90% to the cure rate of hepatitis B.
Medicine of the present invention has following characteristics: hepatitis B is had significant curative effect, and to cirrhosis, liver ascites also has obvious curative effect; Nontoxic, have no side effect; Medicine source abundance; It is convenient to concoct; Inexpensive.
Claims (2)
1, the Chinese herbal medicine of control hepatitis B, the prescription composition has Herba Artemisiae Scopariae, Carapax Trionycis, Poria, Semen Phaseoli, Spica Prunellae, Radix Bupleuri, Radix Glycyrrhizae etc., it is characterized in that also including in the described prescription composition Herba lespedezae pilosae, Herba Kalimeridis grass, Herba Salviae Chinensis, LUODIHONG, Oryza sativa L. var. glutinosa Matsum. grass.
2, the Chinese herbal medicine of control hepatitis B according to claim 1 is characterized in that described Herba lespedezae pilosae content is that 20-30 gram/pair, Herba Kalimeridis grass content are that 20-30 gram/pair, Herba Salviae Chinensis content are that 15-20 gram/pair, LUODIHONG content are that 20-25 gram/pair, the careless content of Oryza sativa L. var. glutinosa Matsum. are 15-20 gram/pair.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98100776 CN1229653A (en) | 1998-03-23 | 1998-03-23 | Chinese herbs medicine for preventing and treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98100776 CN1229653A (en) | 1998-03-23 | 1998-03-23 | Chinese herbs medicine for preventing and treating hepatitis B |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1229653A true CN1229653A (en) | 1999-09-29 |
Family
ID=5216243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 98100776 Pending CN1229653A (en) | 1998-03-23 | 1998-03-23 | Chinese herbs medicine for preventing and treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1229653A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101961366A (en) * | 2010-10-19 | 2011-02-02 | 贵州师范大学 | Preparation method of malan straw extract, malan straw product, pharmaceutical composition and application thereof |
-
1998
- 1998-03-23 CN CN 98100776 patent/CN1229653A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101961366A (en) * | 2010-10-19 | 2011-02-02 | 贵州师范大学 | Preparation method of malan straw extract, malan straw product, pharmaceutical composition and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN1742939B (en) | Medicine for treating pulmonary fibrosis and preparing method | |
| CN101152400A (en) | Traditional Chinese medicine for treating simple goiter | |
| CN1062157C (en) | Hepatitis B curing toxin-dissipating pill | |
| CN101164588A (en) | Traditional Chinese medicine for treating yin deficiency and fire excess type palpitation | |
| CN101152539A (en) | Traditional Chinese medicine for treating acute icteric hepatitis | |
| CN101152536A (en) | Traditional Chinese medicine for treating hashimoto thyroiditis | |
| CN101152519A (en) | Traditional Chinese medicine for treating pregnancy-induced hypertension syndrome | |
| CN100522226C (en) | Composition of Chinese traditional medicine for treating coronary heart disease | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN1229653A (en) | Chinese herbs medicine for preventing and treating hepatitis B | |
| CN101757444A (en) | Orally administrated medicine for Chinese traditional treatment of thyroid nodule | |
| CN101152473A (en) | Traditional Chinese medicine for treating galactorrhea caused by liver depression transforming into heat | |
| CN1792372A (en) | Traditional Chinese medicine prepn. for treating diabetes | |
| CN113456728A (en) | A Chinese medicinal oral liquid for treating chronic hepatitis B, and its preparation method | |
| CN2169437Y (en) | Heart-protecting fragrant pendant | |
| CN1225823A (en) | Chinese medicine for treating diabetes and preparation method therefor | |
| CN1745821A (en) | Chinese medicinal preparation for treating AIDS | |
| CN115708848B (en) | External lotion for treating dermatosis caused by human papilloma virus infection | |
| CN1695639A (en) | Chinese traditional medicine for treating dysmenorrhea and irregular menses, and preparation method | |
| CN1180808C (en) | Chinese medicine for treating rheumatic and rheumatoid diseases | |
| CN1136896C (en) | Live-nourishing 'yanggan' pill | |
| CN1101850A (en) | Tianfengjiehegao ointment for curing tuberculosis | |
| CN101143194A (en) | Traditional Chinese medicine for treating interstitial pneumonia | |
| CN1857687B (en) | Hepatitis B treating Chinese herbal medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |